Oman vs Serbia: HIV/AIDS deaths averted by antiretroviral therapy, per capita
Oman
0 deaths per person
in 2024
Serbia
0 deaths per person
in 2024
Oman rank
129th
Serbia rank
128th
HIV/AIDS deaths averted by antiretroviral therapy, per capita over time
- Oman
- Serbia
How they compare
Serbia currently reports 0 deaths per person against 0 deaths per person in Oman, a difference of 0 deaths per person.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Serbia ahead.
Oman ranks 129th and Serbia ranks 128th of 157 countries.
Across the 4 decades both report, Oman averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Oman | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths per person | 0 deaths per person | 0 deaths per person | — |
| 2000s | 0 deaths per person | 0 deaths per person | 0 deaths per person | Oman |
| 2010s | 0 deaths per person | 0 deaths per person | 0 deaths per person | Serbia |
| 2020s | 0 deaths per person | 0 deaths per person | 0 deaths per person | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, per capita, Oman or Serbia?
- Serbia, at 0 deaths per person against 0 deaths per person in Oman as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy, per capita between Oman and Serbia?
- 0 deaths per person, with Serbia ahead.
- How many years of comparable data are there for Oman and Serbia?
- 35 years are reported by both, from 1990 to 2024.
- How do Oman and Serbia rank globally for hiv/aids deaths averted by antiretroviral therapy, per capita?
- Oman ranks 129th and Serbia ranks 128th of 157 countries.
- Where does this data come from?
- Statizoid (derived), published as HIV/AIDS deaths averted by antiretroviral therapy, per capita. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
HIV/AIDS deaths averted by antiretroviral therapy divided by Population, total, matched on country and year. Neither publisher issues this ratio as a series; it is computed here from both.